VisionCare Ophthalmic Technologies Raises $31 Million In Series E
This article was written by Amit Chowdhry. You can follow me at @amitchowdhry or on Google+ at +AmitChowdhry
VisionCare Ophthalmic Technologies is a company that developers advanced visual prosthetic devices for improving vision for patients that have end-stage age-related macular degeneration. VisionCare has raised $31 million in Series E funding led by Saints Capital. Giza Ventures, General iFinancial Holdings, BSI SA, Pitango Venture Capital, Three Arch Partners, ONSET Ventures, and Newbury Acquisitions Fund/Infinity CSVC Management also joined in this round. Elka Nir, the Managing Director and head of Life Sciences of Giza, will be joining the VisionCare board of directors.
VisionCare’s lead product is the Implantable Miniature Telescope. The product was named in the “Best of What’s New” 2010 by Popular Science magazine. The implant improves visual acuity and reduces the impact of the blind spot caused by end-stage AMD.